secwatch.observer — SEC 8-K summary
======================================

Issuer:     iSpecimen Inc. (ISPC)
CIK:        0001558569
Form:       8-K
Filed at:   2022-11-28T23:59:59+00:00
Accession:  0001104659-22-122450
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

iSpecimen appoints Joseph J. Basile to board, replacing departing director Margaret H. Lawrence
--------------------------------------------------------------------------------

- Margaret H. Lawrence resigned as director effective Nov 15, 2022; vacancy filled by Joseph J. Basile effective Nov 28, 2022.
- Mr. Basile appointed to audit committee and nominating & corporate governance committee; independent director under Nasdaq rules.
- Mr. Basile has extensive M&A experience; currently founder of Pari Passu M&A Mediation and Senior Advisor at Hogan Lovells.
- No family relationships or transactions with the company; standard director indemnification agreement entered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1558569/000110465922122450/0001104659-22-122450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1558569/000110465922122450/tm2231481d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-122450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer